Article:
Surgical results of non-small cell lung cancer in Nepal

creativeworkseries.issnJNMA Print ISSN: 0028-2715; Online ISSN: 1815-672X
dc.contributor.authorThakur, Binay
dc.contributor.authorDi Yonghui
dc.contributor.authorDevekota, Mukti
dc.contributor.authorBaral, Paribartan
dc.contributor.authorPoudel, Bishworam
dc.creator.affiliationDepartment of Surgical Oncology, B. P. Koirala Memorial Cancer Hospital, Nepal.
dc.creator.affiliationDepartment of Surgical Oncology, B. P. Koirala Memorial Cancer Hospital, Nepal.
dc.creator.affiliationDepartment of Surgical Oncology, B. P. Koirala Memorial Cancer Hospital, Nepal.
dc.creator.affiliationDepartment of Surgical Oncology, B. P. Koirala Memorial Cancer Hospital, Nepal.
dc.creator.affiliationDepartment of Surgical Oncology, B. P. Koirala Memorial Cancer Hospital, Nepal.
dc.date.accessioned2026-10-06T05:13:34Z
dc.date.available2026-10-06T05:13:34Z
dc.date.issued2014
dc.description.abstractAbstract Introduction: Surgery remains the only curative modality for early stage of Non small cell lung caner (NSCLC). We reviewed overall scenario of lung cancer and surgical results in Nepal. Methods: 1000 patients with the pathological diagnosis of lung cancer were analyzed to summarize the overall scenario of lung cancer. 157 NSCLC patients underwent pulmonary resection. cIA, IB, IIA, IIB, IIIA (N1) underwent surgery as initial modality of treatment. cIIIA (N2) patients were taken for surgery after neoadjuvant chemo/ chemoradiation. Results: Analysis of 1000 patients showed squamous cell carcinoma in 41.3%, incurable stage (IIIB/ IV) in 66.8% and rate of curative resection in 6.7% cases. Surgery as a single modality of treatment was used in 38%. Neoadjuvant Chemo/ chemoradiation/ radiation followed by surgery and surgery followed by chemo/ chemoradiation/ radiation was done in 12% and 50%, respectively. In-hospital mortality was 2% (post pneumonectomy: 5.5%; post lobectomy: 1.5%; post sublobar resection: 0%). R0 resction was achieved in 91% cases. Median survival and 5-year overall survival were 36 months and 18%, respectively. Better survival was achieved in pI-II vs pIII/ IV, pN0-1 vs pN2 and pR0 vs pR+ (p <0.05). Conclusions: Earlier stage (pI-II), R0 resection and pathological pNo-1 has the best five year overall survival in Nepalese patients with NSCLC as well. Keywords: Lung cancer; NSCLC; Pulmonary resection.
dc.identifier.doihttps://doi.org/10.31729/jnma.2800
dc.identifier.urihttps://hdl.handle.net/20.500.14572/7966
dc.language.isoen_US
dc.publisherNepal Medical Association
dc.subjectLung cancer
dc.subjectNSCLC
dc.subjectPulmonary resection
dc.titleSurgical results of non-small cell lung cancer in Nepal
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage996
oaire.citation.startPage992
relation.isJournalIssueOfPublication52658252-c299-4e73-8477-994dfd16a0d2
relation.isJournalIssueOfPublication.latestForDiscovery52658252-c299-4e73-8477-994dfd16a0d2
relation.isJournalOfPublicatione6e146a0-0ece-4aba-aa0a-6ccfbd10a12a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
992-996.pdf
Size:
1.12 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections